NovoCure
NVCR
NVCR
307 hedge funds and large institutions have $6.79B invested in NovoCure in 2022 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 94 increasing their positions, 113 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 310 → 307 (-3)
17% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 113
25% less call options, than puts
Call options by funds: $78.1M | Put options by funds: $104M
Holders
307
Holding in Top 10
4
Calls
$78.1M
Puts
$104M
Top Buyers
| 1 | +$242M | |
| 2 | +$51.9M | |
| 3 | +$37.3M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$21.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$18.3M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$22.7M | |
| 3 | -$20.6M | |
| 4 |
DCP
Darsana Capital Partners
New York
|
-$19.4M |
| 5 |
Renaissance Technologies
New York
|
-$10.9M |